Renata PLC (DSE:RENATA)
Bangladesh · Delayed Price · Currency is BDT 466.30
+2.90 (0.63%)
At close: Sep 3, 2026
Renata Market Cap
Renata has a market cap or net worth of 53.48 billion as of September 4, 2026. Its market cap has decreased by -7.46% in one year.
Market Cap
53.48B
Enterprise Value
71.36B
Revenue
44.93B
Ranking
n/a
PE Ratio
19.59
Stock Price
466.30
ChartMarket Cap Chart
Since June 2, 2003, Renata's market cap has increased from 320.77M to 53.48B, an increase of 16,573.22%. That is a compound annual growth rate of 24.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 53.48B | 19.01% |
| Dec 30, 2025 | 44.94B | -38.31% |
| Dec 30, 2024 | 72.84B | -47.85% |
| Dec 27, 2023 | 139.69B | - |
| Dec 29, 2022 | 139.69B | -0.67% |
| Dec 30, 2021 | 140.64B | 30.38% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Square Pharmaceuticals PLC. | 192.89B |
| Unilever Consumer Care | 38.59B |
| Beacon Pharmaceuticals | 24.62B |
| The ACME Laboratories | 16.74B |
| Asiatic Laboratories | 13.34B |
| The IBN SINA Pharmaceutical Industry | 9.84B |
| Navana Pharmaceuticals | 7.26B |
| Orion Pharma | 6.18B |